London, June 23, 2022 (GLOBE NEWSWIRE) — Roots Analysis has announced the addition of the “Viral Vaccine Cell Culture Media Market, 2022–2035” report to its list of offerings.
Vaccine production is a highly regulated and challenging process; specifically, the production of viral components or whole viruses further adds to the complexity. Additionally, it is paramount for vaccine cultures to be devoid of any contamination and be highly effective. In order to mitigate the aforementioned challenges, pharma and biotech companies are gradually adopting viral vaccine cell culture media for the manufacturing of vaccines.
To order this 175+ page report, which features 80+ figures and 100+ tables, please visit https://www.rootsanalysis.com/reports/viral-vaccine-cell-culture-media-market.html
Key Market Insights
Presently, more than 80 viral vaccine cell culture media are offered by multiple players
This segment of the industry is dominated by the presence of large players (more than 200 employees) and start-ups / small players (2-50 employees), which collectively represent more than 75% of the total viral vaccine cell culture media developers. In addition, about 35% of the firms were founded post 2010.
70% of the cell culture media are intended to support suspension cell culture
Serum free media has emerged as the most preferred option for suspension cell culture, featuring more than 65% of the overall viral vaccine cell culture media. This is followed by…
